文献速递生殖医学妇科

儿童卵巢组织冷冻保存:采用更新版爱丁堡标准进行适当患者选择

Cryopreservation of paediatric ovarian tissue with an updated version of the Edinburgh criteria for appropriate patient selection.
PubMed 文献 · Reprod Biomed Online · 2021-10-24

这项回顾性和前瞻性观察性队列研究在大学医院开展,评估修订后的儿童和青少年生育力保存患者选择标准。74名转诊咨询的儿童和青少年中,31名(41.9%)按修订标准行卵巢组织冷冻保存;31例中2例术后出现并发症(感染和药物过敏),1例白血病患者(3.2%)提取的卵巢组织存在微小残留病。14名完成治疗且年龄大于12岁的患者中,12名(85.7%)在治疗后一年以上出现早发性卵巢功能不全。

要点

  • 74名转诊儿童和青少年中31名(41.9%)按修订标准行卵巢组织冷冻保存。
  • 31例中2例术后并发症(感染和药物过敏),1例白血病患者(3.2%)卵巢组织有微小残留病。
  • 14名完成治疗且大于12岁患者中12名(85.7%)治疗后一年以上出现早发性卵巢功能不全。

核心结论

  • 儿童和青少年生育力保存的原发病和患者年龄各异,作者认为其患者选择标准在短期随访期内可能是适当的。

研究设计与样本

  • 回顾性和前瞻性观察性队列研究,在大学医院开展,该医院经学术学会批准可进行生育力保存。
  • 调查儿童特征和生育力保存咨询过程,并在18岁前接受卵巢组织冷冻保存的患者中确认死亡率、内分泌谱和月经周期的纵向变化。

主要发现

  • 74名转诊咨询的儿童和青少年中40名(54.1%)患有血液病,包括罕见病患者。
  • 患者平均年龄11.1±4.3岁(中位数12岁,范围1-17岁)。
  • 按修订标准,31名(41.9%)患者行卵巢组织冷冻保存。
  • 31例中2例术后出现并发症(感染和药物过敏),1例白血病患者(3.2%)提取的卵巢组织存在微小残留病。
  • 14名完成治疗且年龄大于12岁的患者中,12名(85.7%)在治疗后一年以上出现早发性卵巢功能不全。

关键数值与推荐

  • 31例中2例(6.5%)因原发病复发死亡(中位数28个月,范围0-60个月)。
  • 向5名生化指标提示早发性卵巢功能不全的患者建议卵母细胞冷冻保存作为额外补救性生育力保存治疗(操作待进行)。

局限性

  • 作者结论称其患者选择标准在短期随访期内可能是适当的。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Are the revised patient selection criteria for fertility preservation of children and adolescents appropriate? DESIGN: A retrospective and prospective observational cohort study implemented at a university hospital approved for fertility preservation by an academic society. The characteristics of children and the process of fertility preservation consultation were investigated. Mortality, the longitudinal course of the endocrine profile and the menstrual cycle were confirmed in patients who underwent ovarian tissue cryopreservation (OTC) before the age of 18 years. RESULTS: Of the 74 children and adolescents referred for a fertility preservation consultation, 40 (54.1%) had haematological disease, which included patients with rare diseases. The mean age of patients was 11.1 ± 4.3 years (median 12 years, range 1-17 years). In accordance with the revised criteria, 31 (41.9%) patients had their ovarian tissue cryopreserved. Two out of 31 had complications after surgery (infection and drug allergy) and one patient with leukaemia (3.2%) had minimum residual disease on the extracted ovarian tissue. Of the 14 patients (>12 years) who completed treatment, 12 (85.7%) had primary ovarian insufficiency (POI) more than a year after treatment. Two out of 31 (6.5%) died because of recurrence of their underlying disease (median 28 months, range 0-60 months). Oocyte cryopreservation, as an additional and salvage fertility preservation treatment, was suggested to five patients with biochemical status POI (procedures pending). CONCLUSION: The primary disease and patients' ages varied in fertility preservation for children and adolescents. Our patient selection criteria might be appropriate over a short follow-up period.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Takae S, Furuta S, Iwahataa H, et al. Cryopreservation of paediatric ovarian tissue with an updated version of the Edinburgh criteria for appropriate patient selection. Reprod Biomed Online. 2021. PMID: 35279375. doi:10.1016/j.rbmo.2021.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。